Institutions / Gabelli Funds LLC / Activity
Activity — Gabelli Funds LLC
115 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | New | 98421M114 Common stock | $2.6K | +29K | 29,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | G2847J112 Common stock | $3.0K | +49K | 49,300 <0.01% of portfolio | low |
| Q1 2026 as of | New | G2851K112 Common stock | $12.9K | +161K | 161,400 <0.01% of portfolio | low |
| Q1 2026 as of | New | enCore Energy Corp. Common stock | $18.0K | +10K | 10,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | CGTX Cognition Therapeutics Inc Common Stock | $22.8K | +30K | 30,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | 74102N119 Common stock | $22.9K | +28K | 28,300 <0.01% of portfolio | low |
| Q1 2026 as of | New | Cyabra, Inc. Common stock | $25.7K | +14K | 13,905 <0.01% of portfolio | low |
| Q1 2026 as of | New | G01336117 Common stock | $28.4K | +114K | 113,800 <0.01% of portfolio | low |
| Q1 2026 as of | New | G6791A118 Common stock | $28.9K | +115K | 115,400 <0.01% of portfolio | low |
| Q1 2026 as of | New | G81306113 Common stock | $31.4K | +110K | 110,050 <0.01% of portfolio | low |
| Q1 2026 as of | New | G25014112 Common stock | $31.8K | +177K | 176,900 <0.01% of portfolio | low |
| Q1 2026 as of | New | 269710117 Common stock | $34.7K | +25K | 24,950 <0.01% of portfolio | low |
| Q1 2026 as of | New | Tecogen Inc. Common stock | $51.2K | +20K | 20,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Rapid7, Inc. Common stock | $72.6K | +13K | 13,168 <0.01% of portfolio | low |
| Q1 2026 as of | New | G3864J118 Common stock | $76.6K | +255K | 255,300 <0.01% of portfolio | low |
| Q1 2026 as of | New | Titan International Inc Common stock | $107.1K | +16K | 15,500 <0.01% of portfolio | low |
| Q1 2026 as of | New | G3730U107 Common stock | $112.7K | +11K | 11,200 <0.01% of portfolio | low |
| Q1 2026 as of | New | NUCL Eagle Nuclear Energy Corp. Common Stock | $116.7K | +15K | 15,195 <0.01% of portfolio | low |
| Q1 2026 as of | New | Relay Therapeutics, Inc. Common stock | $119.4K | +12K | 12,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Y95308105 Common stock | $126.9K | +18K | 17,500 <0.01% of portfolio | low |
| Q1 2026 as of | New | CytomX Therapeutics, Inc. Common stock | $155.1K | +33K | 33,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | EquipmentShare.com Inc Common stock | $203.7K | +10K | 10,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Crinetics Pharmaceuticals, Inc. Common stock | $217.9K | +6K | 6,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | CELC Celcuity Inc. Common Stock | $228.3K | +2K | 2,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Akamai Technologies Inc Common stock | $229.7K | +2K | 2,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | VAALCO Energy Inc Common stock | $240.9K | +38K | 38,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Medline Inc. Common stock | $244.8K | +6K | 5,500 <0.01% of portfolio | low |
| Q1 2026 as of | New | Tarsus Pharmaceuticals, Inc. Common stock | $252.5K | +4K | 3,600 <0.01% of portfolio | low |
| Q1 2026 as of | New | Vericel Corp Common stock | $257.4K | +8K | 8,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | G7709Q104 Common stock | $271.0K | +6K | 5,650 <0.01% of portfolio | low |
| Q1 2026 as of | New | FLY Firefly Aerospace Inc. Common Stock | $275.9K | +10K | 9,690 <0.01% of portfolio | low |
| Q1 2026 as of | New | ICON plc Common stock | $276.6K | +3K | 2,500 <0.01% of portfolio | low |
| Q1 2026 as of | New | Unifirst Corp Common stock | $276.7K | +1K | 1,100 <0.01% of portfolio | low |
| Q1 2026 as of | New | Dauch Corporation Common stock | $278.3K | +47K | 46,934 <0.01% of portfolio | low |
| Q1 2026 as of | New | Huntington Ingalls Industries, Inc. Common stock | $295.2K | +777 | 777 <0.01% of portfolio | low |
| Q1 2026 as of | New | NIKE, Inc. Common stock | $297.0K | +6K | 5,623 <0.01% of portfolio | low |
| Q1 2026 as of | New | DRS Leonardo DRS, Inc. Common Stock | $303.4K | +7K | 6,815 <0.01% of portfolio | low |
| Q1 2026 as of | New | Gentherm Inc Common stock | $319.5K | +12K | 11,500 <0.01% of portfolio | low |
| Q1 2026 as of | New | Corebridge Financial, Inc. Common stock | $334.0K | +14K | 14,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Protagonist Therapeutics Inc Common stock | $340.3K | +3K | 3,229 <0.01% of portfolio | low |
| Q1 2026 as of | New | YSS York Space Systems Inc. Common Stock | $345.2K | +16K | 15,572 <0.01% of portfolio | low |
| Q1 2026 as of | New | Oxford Industries Inc Common stock | $385.1K | +10K | 10,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | 60646V105 Common stock | $430.0K | +62K | 61,700 <0.01% of portfolio | low |
| Q1 2026 as of | New | Alignment Healthcare, Inc. Common stock | $440.5K | +25K | 25,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Tandem Diabetes Care Inc Common stock | $479.3K | +25K | 25,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | G6S74K122 Common stock | $488.3K | +48K | 48,300 <0.01% of portfolio | low |
| Q1 2026 as of | New | White Pearl Acquisition Corp. Common stock | $492.0K | +50K | 49,900 <0.01% of portfolio | low |
| Q1 2026 as of | New | Fortress Value Acquisition Corp. V Common stock | $500.5K | +50K | 49,900 <0.01% of portfolio | low |
| Q1 2026 as of | New | 69351T866 Common stock | $511.5K | +10K | 10,000 <0.01% of portfolio | low |
| Q1 2026 as of | New | Coeur Mining, Inc. Common stock | $514.7K | +27K | 27,422 <0.01% of portfolio | low |